Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06191380 · ClinicalTrials.gov registry record · NA
Effects of Cycling and Virtual Reality on Thinking Speed in Persons With MS (PACE-MS)
A NA study, sponsored by Kessler Foundation.
- Completed
- Registry status
- NA
- Development phase
- 23
- Enrollment target
NCT06191380: Completed NA study, sponsored by Kessler Foundation.
NCT06191380 is a NA study that has completed, run by Kessler Foundation. The registered enrollment target is 23 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06191380, a NA study, has completed, sponsored by Kessler Foundation.
- COMPLETED
- Registry status
- NA
- Development phase
- 23 participants
- Enrollment target
Study Summary
To compare the effects of cycling exercise with different types of virtual reality on processing/thinking speed in persons with multiple sclerosis (MS).
Primary Outcome
Response time on a computerized test is conceptualized as a measure of processing speed. Participants are tasked with identifying the direction of the central target stimulus that is flanked by either congruent (\<\<\<\<\<) or incongruent (\>\>\<\>\>) stimuli by pressing the correct keyboard key.
Interventions
- BEHAVIORAL PACE-MS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2024-02-12 |
| Est. Completion | 2025-10-28 |
| Phase | NA |
What the finished NCT06191380 record still lists
NCT06191380 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 23 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which PACE-MS is the first listed.
NCT06191380 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06191380 about?
NCT06191380 is a clinical study titled "Effects of Cycling and Virtual Reality on Thinking Speed in Persons With MS (PACE-MS)". To compare the effects of cycling exercise with different types of virtual reality on processing/thinking speed in persons with multiple sclerosis (MS).
What is the current status of trial NCT06191380?
This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2024-02-12. Estimated completion is 2025-10-28.
What interventions are being tested in trial NCT06191380?
The interventions under investigation include: PACE-MS (BEHAVIORAL).
Who is sponsoring clinical trial NCT06191380?
This trial is sponsored by Kessler Foundation, which has 104 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06191380's enrollment target sits among peer trials
23 1755th of 2000 higher than 245 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03616041 · 23 participants
Capsule Endoscopy for Severe Hematochezia
- NCT04348747 · 23 participants · Phase 2
Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
- NCT04587687 · 23 participants · Phase 2
Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma
- NCT04715022 · 23 participants · Phase 1
Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI